Newsletter
CRISPR Cell Line Generation at Applied StemCell
Applied StemCell specializes in CRISPR-mediated gene editing in cancer cell lines and iPSCs. Researchers are using our models to elucidate SNP-associated phenotypes in patient-derived cell lines:
Contact Information:
Andrew Hilmer, Ph.D.
Associate Director | Business Development
Applied StemCell, Inc.
Email: andrew.hilmer@appliedstemcell.com
Phone: (650)-273-5593